It will go down, the value of MSB will be determined by the success or failure of its clinical trials.
The market cap of MSB is almost a billion, because the market has assigned a value to each program and if a program fails- the value of that program will be removed from the market cap.
Look at what happened when Teva pulled out and everybody assumed the CHF program was worthless, and what happened when the phase 3 interim came through with a pass.
To date (over 10 years) of clinical trials- our tier 1 programs have continued to meet the hurdles of each clinical trial they have been placed in, with no safety issues.
Which is probably why the NIH and Harvard's Boston children's hospital funded their own trials using MSB's patented MSC technology.
TEVA Update, page-14
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |